Pricing Log in Create free account
Saturday 17 October 2026 Export A’s income statement to Excel — free account

Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.96 2.59 −1.48%
Market cap
$49.5B
P/E
34.0×
Fwd P/E
26.3×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Agilent Technologies, Inc. (A) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Agilent Technologies, Inc. (A) trades at a price to free cash flow of 38.4×. Over the past ten years it has ranged from 20.4× (October 2016) to 59.6× (May 2015); the current reading is higher than 83% of that period. That is above the Diagnostics & Research industry median of 35.8× and above the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 36.0× 30.58%
FY2024 27.6× 33.51%
FY2023 20.7× (49.16%)
FY2022 40.6× 10.21%
FY2021 36.9× (8.96%)
FY2020 40.5× 47.45%
FY2019 27.5× 20.31%
FY2018 22.8× (25.69%)
FY2017 30.7× 41.46%
FY2016 21.7× (28.00%)

Quarterly newest first

Period Price to free cash flow Change
Jul 2026 30.7× 2.76%
Apr 2026 29.9× (22.30%)
Jan 2026 38.5× 6.91%
Oct 2025 36.0× 20.41%
43 more quarters

Against its own ten years

Low 20.4× High 59.6×
Ten-year median 30.4×
Current reading's percentile 83

Price to free cash flow against peers

Company Price to free cash flow
DGX Quest Diagnostics Incorporated compare 19.3×
IQV IQVIA Holdings Inc. compare 19.6×
LH Labcorp Holdings Inc. compare 25.2×
IDXX IDEXX Laboratories, Inc. compare 35.8×
MTD Mettler-Toledo International, Inc. compare 37.8×
A Agilent Technologies, Inc. 38.4×
ILMN Illumina, Inc. compare 43.2×
WAT Waters Corporation compare 117×
NTRA Natera, Inc. compare 667×
Diagnostics & Research industry median 35.8×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on A